Literature DB >> 2894041

The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs.

L Steru1, R Chermat, B Thierry, J A Mico, A Lenegre, M Steru, P Simon, R D Porsolt.   

Abstract

1. Mice when suspended by the tail will alternate between active attempts to escape and immobility. Immobility like that measured in the behavioral despair test is reduced by a wide variety of antidepressant agents. 2. The present paper describes a computerized version of this test (ITEMATIC-TST) which in addition to recording immobility measures the power of the movements. 3. Various tricyclic (amitriptyline, desipramine, imipramine), MAOI (clorgyline, moclobemide, nialamide, pargyline, toloxatone) and atypical antidepressants (bupropion, citalopram, indalpine, mianserin, nomifensine, viloxazine) were tested and compared with psychostimulants (d-amphetamine, caffeine), neuroleptics (chlorpromazine, haloperidol, sulpiride), anxiolytics (clobazam, diazepam) and agents acting on the cholinergic system (atropine, oxotremorine). 4. All antidepressants decreased the duration of immobility and most increased the power of movements. 5. The psychostimulants also decreased immobility but only amphetamine increased the power of movements. 6. Neuroleptics increased immobility without affecting the power of movements, whereas anxiolytics increased immobility but decreased the power of movements. 7. Atropine had a profile similar to antidepressants whereas oxotremorine tended to have opposite effects. 8. The results suggest that the automated test system with its two parameters is not only sensitive to antidepressants but could also be useful for generating activity profiles for different kinds of psychotropic agent.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2894041     DOI: 10.1016/0278-5846(87)90002-9

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  39 in total

1.  Instant and Lasting Down-Regulation of NR1 Expression in the Hippocampus is Associated Temporally with Antidepressant Activity After Acute Yueju.

Authors:  Baomei Xia; Hailou Zhang; Wenda Xue; Weiwei Tao; Chang Chen; Ruyan Wu; Li Ren; Juanjuan Tang; Haoxin Wu; Baochang Cai; Ravid Doronc; Gang Chen
Journal:  Cell Mol Neurobiol       Date:  2016-01-29       Impact factor: 5.046

2.  Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level.

Authors:  Elisabeth Barbier; Jia Bei Wang
Journal:  BMC Neurosci       Date:  2009-11-13       Impact factor: 3.288

3.  Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression.

Authors:  Malika El Yacoubi; Saoussen Bouali; Daniela Popa; Laurent Naudon; Isabelle Leroux-Nicollet; Michel Hamon; Jean Costentin; Joëlle Adrien; Jean-Marie Vaugeois
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

4.  A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment.

Authors:  Tatiana Lipina; John Roder
Journal:  Psychopharmacology (Berl)       Date:  2009-12-16       Impact factor: 4.530

5.  Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats.

Authors:  B Pouzet; M Paabøl Andersen; S Hogg
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

6.  In vivo effects of a GPR30 antagonist.

Authors:  Megan K Dennis; Ritwik Burai; Chinnasamy Ramesh; Whitney K Petrie; Sara N Alcon; Tapan K Nayak; Cristian G Bologa; Andrei Leitao; Eugen Brailoiu; Elena Deliu; Nae J Dun; Larry A Sklar; Helen J Hathaway; Jeffrey B Arterburn; Tudor I Oprea; Eric R Prossnitz
Journal:  Nat Chem Biol       Date:  2009-06       Impact factor: 15.040

7.  Reversal of helpless behavior by serotonin uptake blockers in rats.

Authors:  P Martin; P Soubrié; A J Puech
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice.

Authors:  E C Gavioli; C W Vaughan; G Marzola; R Guerrini; V A Mitchell; S Zucchini; T C M De Lima; G A Rae; S Salvadori; D Regoli; G Calo'
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-25       Impact factor: 3.000

9.  Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice.

Authors:  L K Heisler; H M Chu; T J Brennan; J A Danao; P Bajwa; L H Parsons; L H Tecott
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action.

Authors:  Pattipati S Naidu; Aron H Lichtman; Carey C Archer; Everett L May; Louis S Harris; Mario D Aceto
Journal:  Eur J Pharmacol       Date:  2007-03-30       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.